Without considering inheritance of this functional IGF1R SNP, these women exposed to preeclampsia, much like those in the CTS initially evaluated without IGF1R genotyping, would otherwise appear to show no significant reduction in their later life breast cancer incidence (Fig. 2). The gene discussed is IGF1R; the disease is breast carcinoma.